" class="no-js "lang="en-US"> Simon Chowdhury - Medtech Alert
Thursday, November 07, 2024
Simon Chowdhury

Simon Chowdhury

About Simon Chowdhury

Dr. Chowdhury is a consultant medical oncologist and is actively involved in clinical trial research. He received his first degree from the University of Cambridge and qualified as a doctor at Guy’s and St Thomas’ Medical School. He completed his PhD in tumour targeting at University College London and also trained at St George’s and The Royal Marsden Hospitals. Dr. Chowdry was a visiting fellow at Harvard Medical School and the Dana Farber Cancer Institute in Boston, with which he retains strong links. He was a member of the National Cancer Research Institute clinical studies group for Prostate Cancer. He is also the global and national study chair for current studies investigating ways of improving systemic therapy for genitourinary cancers. Simon has authored over 150 papers on urological cancers in peer-reviewed journals (including New England Journal of Medicine, Nature Medicine, the Lancet, Lancet Oncology and the Journal of Clinical Oncology) and has contributed to ten oncology textbooks. He is a member of both the European and American societies of oncology and is actively involved in their annual meetings.

Related Story

RemedyBio Introduces Scientific Advisory Board

May 26 2022

RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery […]